A Cure Is Out There
People with Chronic Complex Diseases deserve the right to live full, productive lives.
People with Chronic Complex Diseases deserve the right to live full, productive lives.
Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME / CFS) affects over 20 million people.
Established in 2012, Open Medicine Foundation (OMF) leads the largest, concerted worldwide nonprofit effort to diagnose,
treat, and prevent ME / CFS and related chronic, complex diseases such as Post Treatment Lyme Disease Syndrome (PTLDS),
and Fibromyalgia.
Open Medicine Foundation Canada (OMFCA) received Charity Status from the Canada Revenue Agency on June 6, 2019.
We launched our relationship with the Collaborative Research Center at CHU Sainte-Justine /Université de Montréal,
on December 11, 2019.
OMF and OMFCA add urgency to the search for answers by driving transformational philanthropy and investments into global research. We have raised over $24 Million from private donors, and facilitated and funded the establishment of
four prestigious ME / CFS Collaborative Research Centres.
Alain Moreau, PhD
Director
Clinical and scientific intervention studies
Ronald W. Davis, PhD
Director
Innovative, collaborative, multi-disciplinary research
Ronald G. Tompkins, MD, ScD
Wenzhong Xiao, PhD
Co-Directors
Clinical and scientific mechanistic studies towards discovering new treatments
Jonas Bergquist, MD, PhD
Director
Research for biomarkers in body and brain
The four, OMF-established, ME / CFS Collaborative Research Centres have launched an international study of the possible conversion of COVID-19 patients to ME / CFS.
This study, which seeks to learn about the pathways involved in the development of ME / CFS, can lead to biomarkers, new treatments, and prevention strategies.
18 world-renowned scientists
2 Nobel laureates
5 National Academy
of Sciences members
Please help us expand our research efforts across the globe.
Every donation brings us closer to a fully funded research effort and the answers we all seek.
"Our donors want to stop millions from suffering and have come to expect research with impeccable credibility. The time is now to attract the kind of serious investment that will speed up our search for a cure and end these debilitating diseases."
*Qualified donees are as follows:
